Quantitative measurement of skeletal alkaline phosphatase to be used as an aid in the management of patients with Paget disease and osteoporosis
Immediatley following collection, mix sample by gently inverting 5 times
Gold serum separator (SST) tube
Ambient (preferred) - 14 days
Refrigerated - 14 days
Frozen - 14 days
Freeze/thaw cycles - stable x3
Immunochemiluminometric (ICMA)
| Age | Male (μg/L) | Female (μg/L) |
| 0 to 5 m | Not established | Not established |
| 6 to 11 m | 48.2−170.2 | 50.4−154.0 |
| 1 y | 41.9−229.6 | 44.2−178.3 |
| 2 y | 41.7−139.4 | 34.9−195.4 |
| 3 to 4 y | 37.2−127.7 | 37.4−96.8 |
| 5 to 6 y | 42.0−104.2 | 31.4−100.8 |
| 7 to 8 y | 59.0−101.3 | 44.0−135.8 |
| 9 to 10 y | 50.4−133.0 | 47.9−150.8 |
| 11 to 12 y | 53.3−156.8 | 24.2−133.3 |
| 13 to 14 y | 77.5−169.8 | 19.8−92.7 |
| 15 to 16 y | 26.8−173.4 | 11.2−30.2 |
| 17 to 18 y | 15.4−69.8 | 8.8−29.0 |
| 19 to 20 y | 12.2−36.6 | 7.7−16.8 |
| 21 to 29 y | 7.4−27.7 | See below |
| 30 to 34 y | 7.0−27.4 | See below |
| 35 to 39 y | 4.0−27.0 | See below |
| 40 to 44 y | 7.4−26.7 | See below |
| 45 to 49 y | 7.5−26.4 | See below |
| 50 to 54 y | 7.5−26.1 | See below |
| 55 to 59 y | 7.5−25.7 | See below |
| 60 to 64 y | 7.5−25.4 | See below |
| 65 to 69 y | 7.6−25.1 | See below |
| 70 to 74 y | 7.6−24.8 | See below |
| 75 to 100 y | 7.6−24.4 | See below |
| Premenopausal | 6.0−22.7 μg/L | |
| Postmenopausal | 8.1−31.6 μg/L |